Dr. Roderick Corriveau joined the NINDS in 2010 as a Program Director for the Alzheimer’s disease portfolio in the Neurodegeneration Cluster. Dr. Corriveau received a bachelor’s degree in biochemistry from Simon Fraser University, and a Ph.D. in Neurosciences from the University of California San Diego. His graduate and postdoctoral studies focused on gene expression and the role of electrical activity in neural circuit development. As an HHMI Postdoctoral Associate at UC Berkeley, he contributed to the discovery of a role for immune molecules in synaptic development and change. Dr. Corriveau was an Assistant Professor at the LSU Health Sciences Center where he investigated the role of NMDA receptor-dependent neural signaling in gene expression and naturally occurring neuronal cell death. Prior to joining NINDS, he was an Associate Professor at the Coriell Institute for Medical Research, where he was the Principal Investigator for the NINDS Repository to promote genetic research in neurodegenerative disease.
Last Modified January 25, 2011